Q2 2025 CV Sciences Inc Earnings Call Transcript

Aug 13, 2025 / 08:30 PM GMT
Release Date Price: $0.05

Key Points

Positve
  • CV Sciences Inc (CVSI) achieved a gross margin of 50.9% in Q2 2025, the highest since 2019, indicating improved cost efficiency.
  • The company maintained its number one position in the natural product retail channel and increased its market share.
  • CV Sciences Inc (CVSI) is launching several new non-cannabinoid products in late 2025, diversifying its product offerings.
  • The acquisition of Elevated Soft Gels is expected to enhance cost efficiency and gross margin through in-source manufacturing.
  • The company generated positive adjusted EBITDA of $59,000 in Q2 2025, marking its first positive adjusted EBITDA since Q2 2019.
Negative
  • Revenue for Q2 2025 was $3.6 million, a decline from $4.0 million in Q2 2024, primarily due to lower unit sales.
  • The overall CBD market remains fragmented and highly competitive, posing challenges for growth.
  • Direct-to-consumer revenues declined by 7% sequentially, attributed to reduced traffic to the company's site.
  • Increased state regulations have negatively impacted unit sales, contributing to the year-over-year revenue decline.
  • The company continues to face a challenging regulatory environment, which affects its operations and growth potential.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CVSI.PK - CV Sciences Inc
Q2 2025 CV Sciences Inc Earnings Call
Aug 13, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the CV Sciences 2nd quarter 2025 earnings conference call.

At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation.

If anyone requires operator assistance during the conference, please press 0 on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Brendan Hawkins. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and good afternoon, everyone. With us today with prepared remarks
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot